MyMD Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Basis of Presentation and Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Major Customers

Major Customers	3 Months Ended
Mar. 31, 2015
Major Customers [Abstract]
Major Customers	Note 16 Major Customers For the three months ended March 31, 2015, two customers each generated more than 10% of the Companys product revenue. In aggregate, sales to these customers accounted for 66% of the Companys product revenue. As of March 31, 2015, the amount due from these two customers was $81,111. This concentration makes the Company vulnerable to a near-term severe impact should the relationships be terminated. For the three months ended March 31, 2014, two customers each generated more than 10% of the Companys product revenue. Sales to these customers accounted for 86% of the Companys product revenue. As of March 31, 2014, the amount due from these customers was $1,546,548.

Major Customers

3 Months Ended

Mar. 31, 2015

Major Customers [Abstract]

Major Customers

Note 16 Major Customers

For the three months ended March 31, 2015, two customers each generated more than 10% of the Companys product revenue. In aggregate, sales to these customers accounted for 66% of the Companys product revenue. As of March 31, 2015, the amount due from these two customers was $81,111. This concentration makes the Company vulnerable to a near-term severe impact should the relationships be terminated.

For the three months ended March 31, 2014, two customers each generated more than 10% of the Companys product revenue. Sales to these customers accounted for 86% of the Companys product revenue. As of March 31, 2014, the amount due from these customers was $1,546,548.